FLGT

Fulgent Genetics

18.68

-0.10-0.53%

After Hours: 18.47 -0.21 -1.12%18:38 06/12 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE17.94/17.70

TODAY RANGE17.75-18.24

VOL684.42K

MARKET CAP511.21M

52 WEEK RANGE13.46-31.04

AVG VOL (3M)526.28K

% TURNOVER2.41%

TURNOVER--

P/E (TTM)-7.5150

% RANGE2.74%

EPS(TTM)-2.3952

P/E(FORWARD)-6.4057

P/B0.4947

BVPS36.39

DIVIDEND--

P/S1.734

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP323.81M

SHARES OUTSTANDING28.40M

NEXT EARNINGS07/30-08/03

FREE FLOAT17.99M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Seeking Alpha·2d ago
These small-cap healthcare stocks pair revenue growth with attractive valuations
TipRanks·06/04 02:10
Top Fulgent Genetics Executives Quietly Trim Their Holdings in Latest Insider Moves
TipRanks·06/02 10:50
Fulgent Genetics Showcases Promising FID-007 Phase 2 Data
TipRanks·06/02 00:00
Fulgent Genetics presents updated FID-007 data at ASCO 2026
TipRanks·05/29 02:11
Top Fulgent Genetics Executives Quietly Cash In on Recent Stock Moves
TipRanks·05/21 23:48
Fulgent Genetics Highlights Promising FID-007 Phase 2 Results
Benzinga·05/21 21:09
Fulgent Genetics' FID-007 Plus Cetuximab Shows 60% Response Rate And 7.2-Month Median PFS In Phase 2 Head And Neck Cancer Study With Favorable Safety Profile
PUBT·05/21 21:03
Fulgent posts Phase 2 data: FID-007 plus cetuximab shows 60% ORR in HNSCC
Reuters·05/21 21:03
FULGENT ANNOUNCES RAPID ORAL FULL ABSTRACT PUBLICATION FOR FID-007 WITHIN THE HEAD AND NECK CANCER TRACK SESSION AT THE ASCO 2026 ANNUAL MEETING
TipRanks·05/14 21:45
Fulgent Genetics Shareholders Approve New 2026 Equity Plan
Dow Jones·05/05 18:21
Fulgent Genetics Price Target Cut to $15.00/Share From $30.00 by Piper Sandler
Benzinga·05/05 18:11
Piper Sandler Reiterates Neutral on Fulgent Genetics, Lowers Price Target to $15
TipRanks·05/05 11:00
Fulgent Genetics price target lowered to $15 from $30 at Piper Sandler
Reuters·05/05 07:07
U.S. RESEARCH ROUNDUP-Applied Materials, Axsome Therapeutics, Onsemi
Reuters·05/05 03:12
FULGENT GENETICS INC <FLGT.O>: PIPER SANDLER CUTS TARGET PRICE TO $15 FROM $30

Same Industry

Name/Symbol

Change%

Price

Fulgent Genetics

FLGT

-0.53%

18.68

Hca Healthcare Inc

HCA

+1.99%

396.93

Chemed Corp

CHE

+1.00%

423.49

UHS

LH-WI

Labcorp Holdings Inc

+0.34%

266.16

AMN

DGX

DVA

Tenet Healthcare Corp

THC

-2.76%

178.50

ENSG

Corvel Corp

CRVL

-2.40%

58.89

Addus Homecare Corp

ADUS

+0.38%

94.23

Cvs Health Corp

CVS

-1.00%

100.94

Acadia Healthcar

ACHC

-5.96%

23.50

EHC

EHC-WI

U S Physical Therapy

USPH

+1.33%

66.39

PINC

ENSGV

SEM

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.